Researchers at the University of Southern Santa Catarina in Brazil have conducted a comprehensive review, revealing the potential of “classic psychedelics” such as LSD, psilocybin, and ayahuasca in treating alcohol use disorder (AUD).
LSD (top left), dried psilocybin mushrooms (top right), ayahuasca (bottom left), and beer (bottom right).
The study, published in the journal Progress in Neuro-Psychopharmacology and Biological Psychiatry, highlights the pharmacotherapeutic effects of these substances, particularly in cases where traditional treatments have failed.
The study’s abstract emphasizes the challenge posed by alcohol dependence, noting that it is often resistant to conventional treatment methods. “Classic psychedelics have demonstrated promising pharmacotherapeutic effects in the treatment of treatment-resistant psychopathological conditions, such as addiction, especially related to alcohol dependence,” the researchers wrote. They attribute these effects to the substances’ ability to modulate neuroplasticity in the brain, which could play a crucial role in overcoming addiction.
The review further notes that, unlike many substances used in addiction treatment, serotonergic psychedelics do not produce physical dependence or withdrawal symptoms with repeated use. This characteristic makes them a promising option for managing drug use disorders, including AUD.
“Psychedelic substances have demonstrated potential for treating drug addiction, especially AUD, mostly by modulating neuroplasticity in the brain”, states the study. “Given that serotonergic psychedelics do not produce physical dependence or withdrawal symptoms with repeated use, they may be considered promising treatment options for managing drug use disorders. ”
However, the study also acknowledges certain limitations. While many participants in clinical trials have achieved positive results with a single dose of a psychedelic substance, the duration of these effects varies significantly among individuals. The researchers suggest that further studies are needed to explore different dosing protocols and experimental approaches to strengthen the evidence supporting the use of psychedelics in treating alcoholism.
For more information on this study, click here.
